When COVID-19 travel restrictions were introduced, it sparked a trend towards remote participation in clinical assessments of new medicines’ safety and efficacy. A new study co-authored at Cambridge Judge Business School outlines a framework to assess when decentralised drug trials provide the greatest value to the system.

Increased drug supply security and reduced costs has been achieved by Civica Rx, a health care utility taking a fresh approach, says study in NEJM Catalyst authored by 2 Cambridge Judge Business School academics.

Stefan Scholtes of Cambridge Judge Business School wins Collaboration Award in the Vice Chancellor’s Awards for Research Impact and Engagement for work on the COVID pandemic. Khal Soufani of Cambridge Judge is runner-up in Established Academic award for work in circular economy.

A new Healthcare Utility Initiative to develop not-for-profit healthcare business models is launched by Cambridge Judge Business School and SSM Health.

Faculty news

Clear impact

Cambridge Judge faculty members Stefan Scholtes and Robert Wardrop are named recipients of the 2021 Sandra Dawson Research Impact Award.

Apollo Therapeutics, a life sciences company led by Cambridge Judge Business School alumnus and Fellow Dr Richard Mason (MBA 1999), completes $145 million financing.

'Second opinion' by another prescribing doctor within 30 days of an opioid prescription reduces long-term opioid use by 31%, concludes a new study led at Cambridge Judge Business School.

A new CJBS COVID-19 Tracker for India, developed by Cambridge Judge Business School and the National Institute of Economic and Social Research in India working with Health Systems Transformation Platform in India, provides forecasts of the pandemic's trajectory based on a recently developed model.

New study co-authored by Dr Paul Kattuman of Cambridge Judge develops new time series models to predict epidemic trajectories before they reach peak.

Working with Public Health England and the NHS in the East of England on responses to COVID-19 (coronavirus). A team of a dozen faculty and PhD students at Cambridge Judge Business School is working with Public Health England and the NHS in the East of England on several projects relating to responding to the coronavirus response. The projects look at how COVID-19 is affecting the East of England, in order to better plan for capacity at various facilities. At the same time, the project looks at how organisations improvise and innovate in real-time at times of major disruption. The projects are expected to last for several months, and there are no results ready to be announced at this point. Specifically, the projects focus on: short-term projections of hospital bed and intensive care capacity requirements for COVID-19 patients in the East of Englandmedium-term modeling of disease progression and health system usage in the East of England, and in particular the timing and strength of peak resource usagemodelling the effects of policy interventions, such as school closures and lock-downs, on COVID-19-related local health resource usage in both primary and secondary careidentifying lead indicators of future local flare-ups of COVID-19 clusters from primary…

Read all news & insight from the Centre for Health & Leadership Enterprise

In the media

Business Weekly | 6 September 2023

Gift from the gods as Apollo closes $226.5m Series C

Fellow of Centre for Health & Leadership Enterprise is quoted in an article about how his company announced the close of a blockbusting $226.5 million Series C round led by California’s Patient Square Capital.